Author:
Klont Frank,Hof Marieke A.J.,Nijdam Fleur B.,Touw Daan J.,Bakker Stephan J.L.,Hopfgartner Gérard,Kosterink Jos G.W.,Hak Eelko
Funder
Netherlands Organisation for Scientific Research
Horizon 2020
Horizon 2020 Framework Programme
Horizon 2020 Marie Skłodowska-Curie Actions
Reference7 articles.
1. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines;Abdullah-Koolmees;Front Pharm.,2021
2. Metabolism-mediated drug–drug interactions – Study design, data analysis, and implications for in vitro evaluations;Fu;Med Drug Discov.,2022
3. Human radiolabeled mass balance studies supporting the FDA approval of new drugs;Ramamoorthy;Clin. Transl. Sci.,2022
4. Untargeted ‘SWATH’ mass spectrometry-based metabolomics for studying chronic and intermittent exposure to xenobiotics in cohort studies;Klont;Food Chem. Toxicol.,2022
5. Assessing the potential of untargeted SWATH mass spectrometry-based metabolomics to differentiate closely related exposures in observational studies;Klont;Metabolites,2022